Proteomic analysis of EZH2 downstream target proteins in hepatocellular carcinoma

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Proteomics

• Publication date

  2007-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/pmic.200700019PMID 17676662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53

  2007cited by this paper
• Lentivirus‐mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down‐regulation of stathmin

  2007cited by this paper
• The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens

  2006cited by this paper
• The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer

  2006cited by this paper
• Comparative proteomic analysis of nucleic acid-binding proteins in ten human tumor cell lines.

  2006cited by this paper
• Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis

  2006cited by this paper
• Structural intermediates in microtubule assembly and disassembly: how and why?

  2006cited by this paper
• Identification of differentially expressed, tumor‐associated proteins in oral squamous cell carcinoma by proteomic analysis

  2006cited by this paper
• HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.

  2006cited by this paper
• Identification of novel phosphoproteins in signaling pathways triggered by latent membrane protein 1 using functional proteomics technology

  2006cited by this paper
• Silencing stathmin gene expression by survivin promoter-driven siRNA vector to reverse malignant phenotype of tumor cells

  2006cited by this paper
• Expression of the Op18 gene is maintained by the CCAAT-binding transcription factor NF-Y.

  2006cited by this paper
• Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma

  2006cited by this paper
• Restoration by IL-15 of MHC Class I Antigen-Processing Machinery in Human Dendritic Cells Inhibited by Tumor-Derived Gangliosides1

  2005cited by this paper
• p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.

  2005cited by this paper
• Proteomic analysis of hepatitis B virus‐associated hepatocellular carcinoma: Identification of potential tumor markers

  2005cited by this paper
• Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma

  2005cited by this paper
• Expression of Polycomb-group genes in human ovarian follicles, oocytes and preimplantation embryos.

  2005cited by this paper
• Proteomic profiling for cancer progression: Differential display analysis for the expression of intracellular proteins between regressive and progressive cancer cell lines

  2005cited by this paper
• Heat‐shock protein 27: A potential biomarker for hepatocellular carcinoma identified by serum proteome analysis

  2005cited by this paper
• A meta-analysis of case–control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China

  2005cited by this paper
• p27Kip1-stathmin interaction influences sarcoma cell migration and invasion

  2005cited by this paper
• ERp57 is present in STAT3-DNA complexes.

  2004cited by this paper
• Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines.

  2004cited by this paper
• Identification of Phosphoproteins and Their Phosphorylation Sites in the WEHI-231 B Lymphoma Cell Line*

  2004cited by this paper
• Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A

  2004cited by this paper
• The role of stathmin in the regulation of the cell cycle

  2004cited by this paper
• Cell Memory and Cancer – The Story of the Trithorax and Polycomb Group Genes

  2004cited by this paper
• EZH2 is downstream of the pRB‐E2F pathway, essential for proliferation and amplified in cancer

  2003cited by this paper
• Polycomb, epigenomes, and control of cell identity.

  2003cited by this paper
• Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene.

  2003cited by this paper
• Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro.

  2003cited by this paper
• EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

  2003cited by this paper
• Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients.

  2003cited by this paper
• Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein.

  2002cited by this paper
• The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells.

  2002cited by this paper
• The polycomb group protein EZH2 is involved in progression of prostate cancer

  2002cited by this paper
• Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing

  2002cited by this paper
• Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease.

  2002cited by this paper
• Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells.

  2002cited by this paper
• Hepatocellular carcinoma: the high-risk patient.

  2002cited by this paper
• Proteome analysis of hepatocellular carcinoma.

  2002cited by this paper
• An integrated proteome database for two‐dimensional electrophoresis data analysis and laboratory information management system

  2002cited by this paper
• Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma

  2002cited by this paper
• Polycomb-group genes as regulators of mammalian lymphopoiesis.

  2001cited by this paper
• Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver

  2001cited by this paper
• Epigenetics: unforeseen regulators in cancer.

  2001cited by this paper
• Trichosanthin interacts with acidic ribosomal proteins P0 and P1 and mitotic checkpoint protein MAD2B.

  2001cited by this paper
• A Role for Calnexin in the Assembly of the MHC Class I Loading Complex in the Endoplasmic Reticulum1

  2001cited by this paper
• Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.

  2001cited by this paper
• Reconstitution of a functional core polycomb repressive complex.

  2001cited by this paper
• The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma

  2001cited by this paper
• Hepatocellular carcinoma.

  2000cited by this paper
• “Slow-down” of the intrahepatic bile duct development between the 2nd and the 3rd trimester of gestation

  2000cited by this paper
• Erratum: Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83, 18–29 (1999).

  1999cited by this paper
• Rising Incidence of Hepatocellular Carcinoma in the United States

  1999cited by this paper
• Stabilization of chromatin structure by PRC1, a Polycomb complex.

  1999cited by this paper
• Polycomb group protein complexes: do different complexes regulate distinct target genes?

  1999cited by this paper
• RING1 Interacts with Multiple Polycomb-Group Proteins and Displays Tumorigenic Activity

  1999cited by this paper
• Rising incidence of hepatocellular carcinoma in the United States.

  1999cited by this paper
• Identification of Apoptosis-associated Proteins in a Human Burkitt Lymphoma Cell Line

  1998cited by this paper
• Interference with the expression of a novel human polycomb protein, hPc2, results in cellular transformation and apoptosis

  1997cited by this paper
• Interaction of the Thiol-Dependent Reductase ERp57 with Nascent Glycoproteins

  1997cited by this paper
• Cloning, expression and genomic organization of human placental protein disulfide isomerase (previously identified as phospholipase C alpha).

  1996cited by this paper
• Ubiquitin-ribosomal protein S27a gene overexpressed in human colorectal carcinoma is an early growth response gene.

  1993cited by this paper
• Drosophila AP3, a presumptive DNA repair protein, is homologous to human ribosomal associated protein P0.

  1991cited by this paper
• The bmi-1 and mel-18 gene products define a new family of DNA-binding proteins involved in cell proliferation and tumorigenesis.

  1991cited by this paper

• Exosomal RNAs and EZH2: unraveling the molecular dialogue driving tumor progression

  2025cites this paper
• Analysis of differentially expressed proteins in lymph fluids related to lymphatic metastasis in a breast cancer rabbit model guided by contrast‑enhanced ultrasound

  2024cites this paper
• MicroRNA-98 as a novel diagnostic marker and therapeutic target in cancer patients

  2024cites this paper
• Acetylation stabilizes stathmin1 and promotes its activity contributing to gallbladder cancer metastasis

  2022cites this paper
• Acetylation stabilizes stathmin1 and promotes its activity contributing to gallbladder cancer metastasis

  2022cites this paper
• Insights into the role of ERp57 in cancer

  2021cites this paper
• Cellular molecular and proteomic profiling deciphers the SIRT1 controlled cell death pathways in esophageal adenocarcinoma cells.

  2020cites this paper
• EZH2 Expression in Naturally Occurring Canine Tumors.

  2018cites this paper
• Lentivirus-mediated overexpression of miR-124 suppresses growth and invasion by targeting JAG1 and EZH2 in gastric cancer.

  2018cites this paper
• Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis

  2018cites this paper
• Identification of an Anti‐Inflammation Protein, Annexin A1, in Tendon Derived Stem Cells (TDSCs) of Cystic Fibrosis Mice: A Comparative Proteomic Analysis

  2018cites this paper
• A Comparative Study of Pentafluorophenyl and Octadecylsilane Columns in High‐throughput Profiling of Biological Fluids

  2017cites this paper
• Oblongifolin M, an active compound isolated from a Chinese medical herb Garcinia oblongifolia, potently inhibits enterovirus 71 reproduction through downregulation of ERp57

  2016cites this paper
• Enhancer of Zeste Homology 2 (Ezh2), an Epigenetic Regulator: A Possibility for Prostate Cancer Treatment

  2016cites this paper
• Targeting EZH2 in cancer

  2016cites this paper
• Hotair mediates hepatocarcinogenesis through suppressing miRNA-218 expression and activating P14 and P16 signaling.

  2015cites this paper
• EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma

  2014cites this paper
• Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.

  2014cites this paper
• Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis.

  2014cites this paper
• Intratumoral Decorin Gene Delivery by AAV Vector Inhibits Brain Glioblastomas and Prolongs Survival of Animals by Inducing Cell Differentiation

  2014cites this paper
• Role of microRNA-95 in the anticancer activity of Brucein D in hepatocellular carcinoma.

  2014cites this paper
• Differential protein analysis of lymphocytes between children with acute lymphoblastic leukemia and healthy children

  2013cites this paper
• Effects of EZH2 gene on the growth and migration of hepatocellular carcinoma HepG2 cells.

  2013cites this paper
• A potential antitumor ellagitannin, davidiin, inhibited hepatocellular tumor growth by targeting EZH2

  2013cites this paper
• Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.

  2013cites this paper
• MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer

  2013cites this paper
• Sorafenib suppresses growth and survival of hepatoma cells by accelerating degradation of enhancer of zeste homolog 2

  2013cites this paper
• MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma

  2012cites this paper
• Separation Technique for the Determination of Highly Polar Metabolites in Biological Samples

  2012cites this paper
• MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2.

  2011cites this paper
• Lentivirus-Mediated RNA Interference Targeting Bax Inhibitor-1 Suppresses Ex Vivo Cell Proliferation and In Vivo Tumor Growth of Nasopharyngeal Carcinoma

  2011cites this paper
• Dependent Hepatocarcinogenesis −-Catenin β Promotes EZH 2-Mediated Concordant Repression of Wnt Antagonists

  2011cites this paper
• Proteomic profiling between CNE‐2 and its strongly metastatic subclone S‐18 and functional characterization of HSP27 in metastasis of nasopharyngeal carcinoma

  2011cites this paper
• EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.

  2011influential citation
• Microinjection Manipulation Resulted in the Increased Apoptosis of Spermatocytes in Testes from Intracytoplasmic Sperm Injection (ICSI) Derived Mice

  2011cites this paper
• Proteomic identification of microRNA‐122a target proteins in hepatocellular carcinoma

  2010cites this paper
• RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivo.

  2010cites this paper
• Comparative serum proteomic analysis of patients with acute‐on‐chronic liver failure: alpha‐1‐acid glycoprotein maybe a candidate marker for prognosis of hepatitis B virus infection

  2010cites this paper
• MiR-26 a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH 2

  2010cites this paper
• Overexpression of Bax inhibitor‐1 (BI‐1) induces cell transformation in NIH3T3 cells

  2010cites this paper
• Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer.

  2009cites this paper
• Glucose-regulated Protein 78 Is an Intracellular Antiviral Factor against Hepatitis B Virus

  2009cites this paper
• Proteomic identification of molecular targets of gambogic acid: Role of stathmin in hepatocellular carcinoma

  2009cites this paper
• Hepatic delivery of RNA interference activators for therapeutic application.

  2009cites this paper
• Running title: GRP78 against HBV

  2009cites this paper
• Modern strategies to identify new molecular targets for the treatment of liver diseases: The promising role of Proteomics and Redox Proteomics investigations

  2009cites this paper
• Sensitive detection and quantitation of EZH2 expression in cancer cell by an electrochemiluminescent method

  2009cites this paper
• Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells.

  2009influential citation
• Down-regulation of stathmin is required for TGF-beta inducible early gene 1 induced growth inhibition of pancreatic cancer cells.

  2009cites this paper
• A proteomic approach to characterizing ciglitazone-induced cancer cell differentiation in Hep-G2 cell line.

  2009cites this paper
• Screening of liver-targeted drugs

  2008cites this paper
• Advance in proteomic study of hepatocellular carcinoma

  2008cites this paper
• Proteomic approaches to cancer target identification

  2007cites this paper
• Effects of Neonatal Resveratrol Exposure on Adult Male and Female Reproductive Physiology and Behavior

  2006cites this paper